T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CXP
2226
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $669K | ﹤0.01% |
35,183
-84
| -0.2% | -$1.46K |
|
2227
StoneX
SNEX
$8.05B
| $665K | ﹤0.01% |
51,055
-2,694
| -5% | -$34.6K |
|
|
COWN
2228
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $664K | ﹤0.01% |
19,354
-917
| -5% | -$34.4K |
|
2229
Axsome Therapeutics
AXSM
$11.2B
| $663K | ﹤0.01% |
20,110
-728,137
| -97% | -$28.4M |
|
2230
Cerus
CERS
$572M
| $663K | ﹤0.01% |
108,944
+359
| +0.3% | +$2.09K |
|
2231
Materion
MTRN
$5.88B
| $661K | ﹤0.01% |
9,636
-251
| -3% | -$18K |
|
2232
Tootsie Roll Industries
TR
$3.02B
| $660K | ﹤0.01% |
25,157
+12,568
| +100% | +$354K |
|
2233
Banner Corp
BANR
$2.5B
| $658K | ﹤0.01% |
11,922
+70
| +0.6% | +$3.77K |
|
2234
NVE Corp
NVEC
$563M
| $655K | ﹤0.01% |
10,232
+47
| +0.5% | +$3.34K |
|
2235
NMI Holdings
NMIH
$3.42B
| $654K | ﹤0.01% |
28,912
-1,557
| -5% | -$34.2K |
|
2236
Cimpress
CMPR
$2.37B
| $653K | ﹤0.01% |
7,521
-1,043
| -12% | -$102K |
|
2237
CVR Energy
CVI
$3.58B
| $653K | ﹤0.01% |
39,187
-79
| -0.2% | -$1.11K |
|
2238
Sonic Automotive
SAH
$2.51B
| $651K | ﹤0.01% |
12,386
+55
| +0.4% | +$2.79K |
|
|
TVTY
2239
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $649K | ﹤0.01% |
28,160
| – | – |
|
2240
Arcus Biosciences
RCUS
$3.67B
| $648K | ﹤0.01% |
18,584
-39
| -0.2% | -$1.21K |
|
2241
SiriusPoint
SPNT
$2.7B
| $647K | ﹤0.01% |
69,873
+200
| +0.3% | +$1.92K |
|
|
SC
2242
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $647K | ﹤0.01% |
15,516
-20,558
| -57% | -$846K |
|
2243
Futu Holdings
FUTU
$14.7B
| $646K | ﹤0.01% |
7,100
+2,947
| +71% | +$325K |
|
2244
Unitil
UTL
$992M
| $646K | ﹤0.01% |
15,111
+143
| +1% | +$7.14K |
|
2245
Purple Innovation
PRPL
$28.7M
| $643K | ﹤0.01% |
1,224
+339
| +38% | +$212K |
|
2246
ATN International
ATNI
$491M
| $642K | ﹤0.01% |
13,694
-60
| -0.4% | -$2.71K |
|
2247
Rocket Companies
RKT
$42.6B
| $642K | ﹤0.01% |
40,029
+800
| +2% | +$14K |
|
2248
iShares National Muni Bond ETF
MUB
$45.9B
| $641K | ﹤0.01% |
5,520
-860
| -13% | -$101K |
|
|
VAPO
2249
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $640K | ﹤0.01% |
3,595
+352
| +11% | +$71.6K |
|
|
HSII
2250
DELISTED
Heidrick & Struggles
HSII
| $639K | ﹤0.01% |
14,307
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.